I agree that this site is using cookies. You can find further informations here.
X
Sancho, Juan‐Manuel
156  results:
Search for persons X
?
1

Real-World Evidence of Relapsed/Refractory Mantle Cell Lymp..:

Sancho, Juan-Manuel ; Sorigué, Marc ; Rubio-Azpeitia, Eva
Journal of Blood Medicine.  15 (2024)  - p. 239-254 , 2024
Link: https://doi.org/10.2147/..
 
?
2

Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therap..:

Bastos-Oreiro, Mariana ; Gutierrez, Antonio ; Cabero, Almudena...
Cancers.  16 (2024)  7 - p. 1285 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Safety and efficacy of parsaclisib in combination with ritu..:

Sancho, Juan-Manuel ; Abrisqueta, Pau ; Kumar, Abhijeet...
Leukemia & Lymphoma.  65 (2024)  7 - p. 911-921 , 2024
Link: https://doi.org/10.1080/..
 
?
4

Progression-free survival after front line, second line and..:

Rajamaki, Aino ; Sorigue, Marc ; Prusila, Roosa E.I....
Acta Oncologica.  63 (2024)  - p. 267-272 , 2024
Link: https://doi.org/10.2340/..
 
?
5

Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in h..:

Huguet, Maria ; Boigues, Marc ; Sorigué, Marc...
Medicina Clínica (English Edition).  162 (2024)  7 - p. 313-320 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Rituximab maintenance after bendamustine-based treatment fo..:

Serna, Ángel ; Navarro, Víctor ; Iacoboni, Gloria...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
7

Treatment outcomes in patients with large B‐cell lymphoma a..:

Iacoboni, Gloria ; Iraola‐Truchuelo, Josu ; O'Reilly, Maeve...
HemaSphere.  8 (2024)  5 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
8

An Updated Comparison of Overall Survival with Brexucabtage..:

Hess, Georg ; Dreyling, Martin ; Oberic, Lucie...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S359-S360 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Epcoritamab monotherapy in patients with relapsed or refrac..:

Linton, Kim M ; Vitolo, Umberto ; Jurczak, Wojciech...
The Lancet Haematology.  , 2024
Link: https://doi.org/10.1016/..
 
?
10

Front‐line and second‐line treatment for mantle cell lympho..:

Harmanen, Minna ; Sorigue, Marc ; Khan, Madiha...
European Journal of Haematology.  113 (2024)  2 - p. 218-226 , 2024
Link: https://doi.org/10.1111/..
 
?
11

Feasibility and outcomes after dose reduction of immunochem..:

Ribera, Josep-Maria ; Morgades, Mireia ; Garcia-Calduch, Olga...
Haematologica.  109 (2023)  2 - p. 543-552 , 2023
Link: https://doi.org/10.3324/..
 
?
12

Real-world Data: MCL2 Protocol Demonstrates Excellent Treat..:

Harmanen, Minna ; Klaavuniemi, Tuula ; Sorigue, Marc...
HemaSphere.  7 (2023)  10 - p. e954 , 2023
Link: https://doi.org/10.1097/..
 
?
13

Indirect treatment comparison of brexucabtagene autoleucel ..:

Hess, Georg ; Dreyling, Martin ; Oberic, Lucie...
Leukemia & Lymphoma.  65 (2023)  1 - p. 14-25 , 2023
Link: https://doi.org/10.1080/..
 
?
14

Safety and efficacy of parsaclisib in combination with obin..:

Hamadani, Mehdi ; Coleman, Morton ; Boccia, Ralph...
Hematological Oncology.  41 (2023)  5 - p. 848-857 , 2023
Link: https://doi.org/10.1002/..
 
?
15

HHV8 and EBV‐negative primary effusion‐based lymphoma: A ca..:

Canelo‐Vilaseca, Marta ; Tapia, Gustavo ; Orna, Elisa...
Clinical Case Reports.  11 (2023)  5 - p. , 2023
Link: https://doi.org/10.1002/..
 
1-15